Public Offering
-
Orange County Bancorp, Inc. Announces Public Offering of Common Stock Pricing
Orange County Bancorp, Inc. (OBT) announced a public offering of 1,720,430 shares at $23.25 each, potentially raising $40-$46 million in gross proceeds. Funds will support general corporate purposes, including growth initiatives, capital strengthening, and potential acquisitions. The offering, managed by Piper Sandler and Stephens, is expected to close June 5, 2025. Investors should review SEC filings for details.
-
Super League Enterprise, Inc. Announces Closing of Underwritten Public Offering
Super League Enterprise (SLE) announced the successful closing of an underwritten public offering on May 30, 2025, raising approximately $550,000 in gross proceeds. The offering involved the sale of common stock at $0.12 per share, including the underwriter’s overallotment option. Funds will be used for general corporate purposes, working capital, and debt repayment, supporting Super League’s mission to revolutionize brand engagement through playable media.
-
TAT Technologies Announces Public Offering Pricing: Ordinary Shares and Secondary Offering by Selling Shareholders
TAT Technologies Ltd. announced the pricing of a public offering of 4,150,000 ordinary shares at $26.00 each. The company will sell 1,625,000 shares, while FIMI Opportunity V and FIMI Israel Opportunity Five will sell 2,525,000. Underwriters have options to purchase additional shares. The offering is expected to close around June 3, 2025, generating approximately $42.3 million in gross proceeds for TAT, allocated towards general corporate needs. Stifel and Truist Securities are joint book-running managers.
-
以下是几个可能的英文标题: * Taysha Gene Therapies Announces Pricing for Public Offering of Common Stock and Pre-Funded Warrants * Taysha Gene Therapies Sets Pricing for Public Offering of Common Stock and Pre-Funded Warrants * Taysha Gene Therapies Reveals Pricing of Public Offering for Common Stock and Pre-Funded Warrants
Taysha Gene Therapies (TSHA) announced a public offering to raise approximately $200 million. The offering includes common stock and pre-funded warrants, priced at $2.75 and $2.749 per share respectively. This capital will advance Taysha’s CNS-focused gene therapy programs, targeting diseases like Rett syndrome with its AAV-based therapies. The deal is expected to close around May 30, 2025.
-
Guardian Pharmacy Services Prices Underwritten Public Offering of Class A Common Stock
Guardian Pharmacy Services (NYSE: GRDN) priced its public offering of 7.5 million Class A shares at $21.00 each, including 6.06 million shares from existing stockholders and 1.44 million new shares. Proceeds from new shares will repurchase 1.44 million converted Class B shares, preventing net dilution. Raymond James leads underwriting with a 30-day option for 1.13 million additional shares. The SEC-approved offering, effective May 22, supports Guardian’s strategy to balance capital allocation while serving long-term care facilities in 38 states.
-
Sable Offshore Corp. Announces Pricing of Upsized Public Offering of Common Stock
Sable Offshore Corp. (SOC) priced an upsized public offering of 8.7 million shares at $29.50 each, targeting ~$256.5 million in gross proceeds. Underwriters J.P. Morgan, Jefferies, and TD Cowen secured an option for an additional 1.3 million shares. Proceeds will fund capital expenditures and corporate needs, with closure expected by May 23 pending approvals. The Houston-based firm, focused on California’s Santa Ynez Unit offshore assets, highlights operational expertise amid regulatory and ESG challenges. Analysts note the pricing reflects cautious optimism as energy equities rebound, though supply chain and permitting risks persist. SEC-declared effective May 1, the offering expands distribution through co-managers including Benchmark Company and Pickering Energy Partners.